Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Neutral
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Integra LifeSciences Holdings (IART)
Surgical & Medical Instruments & Apparatus
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
1100 CAMPUS ROAD
PRINCETON, NJ
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/16/1995
Market Cap
1,692,839,240
Shares Outstanding
78,180,000
Weighted SO
78,175,803
Total Employees
N/A
Upcoming Earnings
07/24/2024
Similar Tickers
Beta
1.1100
Last Div
0.0000
Range
21.08-45.42
Chg
-0.0400
Avg Vol
1641559
Mkt Cap
1692839240
Exch
NASDAQ
Country
US
Phone
609 275 0500
DCF Diff
-34.7266
DCF
56.5866
Div Yield
0.0000
P/S
1.0806
EV Multiple
15.0130
P/FV
1.1009
Div Yield %
0.0000
P/E
71.4253
PEG
102.4983
Payout
0.0000
Current Ratio
3.3879
Quick Ratio
2.1032
Cash Ratio
0.6556
DSO
64.7230
DIO
228.1115
Op Cycle
292.8344
DPO
58.1356
CCC
234.6988
Gross Margin
0.5692
Op Margin
0.0777
Pretax Margin
0.0173
Net Margin
0.0151
Eff Tax Rate
0.1258
ROA
0.0058
ROE
0.0124
ROCE
0.0325
NI/EBT
0.8742
EBT/EBIT
0.2223
EBIT/Rev
0.0777
Debt Ratio
0.4516
D/E
1.1993
LT Debt/Cap
0.5400
Total Debt/Cap
0.5453
Int Coverage
4.5228
CF/Debt
0.0770
Equity Multi
2.6558
Rec Turnover
5.6394
Pay Turnover
6.2784
Inv Turnover
1.6001
FA Turnover
3.0065
Asset Turnover
0.3845
OCF/Share
1.8302
FCF/Share
0.7608
Cash/Share
3.8358
OCF/Sales
0.0904
FCF/OCF
0.4157
CF Coverage
0.0770
ST Coverage
3.6485
CapEx Coverage
1.7114
Div&CapEx Cov
1.7114
P/BV
1.1009
P/B
1.1009
P/S
1.0806
P/E
71.4253
P/FCF
28.7448
P/OCF
11.9219
P/CF
11.9219
PEG
102.4983
P/S
1.0806
EV Multiple
15.0130
P/FV
1.1009
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
163.27K Shares Bought (99.76 %)
392.00 Shares Sold (0.24%)
3 - 6 Months
544.61K Shares Bought (96.94 %)
17.19K Shares Sold (3.06%)
6 - 9 Months
9.81K Shares Bought (33.09 %)
19.85K Shares Sold (66.91%)
9 - 12 Months
10.36K Shares Bought (66.73 %)
5.16K Shares Sold (33.27 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 383.32M | ▲ 395.13M | ▼ 388.65M | ▲ 405.52M | ▼ 398.02M | ▼ 397.04M | ▼ 368.87M |
Cost Of Revenue | 146.46M | ▲ 149.46M | ▼ 147.07M | ▲ 156.25M | ▼ 147.94M | ▲ 163.06M | ▼ 162.04M |
Gross Profit | 236.85M | ▲ 245.67M | ▼ 241.58M | ▲ 249.27M | ▲ 250.09M | ▼ 233.98M | ▼ 206.83M |
Gross Profit Ratio | 0.62 | ▲ 0.62 | ▼ 0.62 | ▼ 0.61 | ▲ 0.63 | ▼ 0.59 | ▼ 0.56 |
Research And Development Expenses | 20.30M | ▲ 24.64M | ▼ 22.18M | ▲ 24.73M | ▲ 26.78M | ▼ 24.31M | ▲ 26.97M |
General And Administrative Expenses | 177.23M | ▼ 174.25M | ▼ 165.95M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | ▼ -3.56M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 177.23M | ▼ 174.25M | ▼ 162.39M | ▼ 162.25M | ▼ 151.92M | ▼ 147.44M | ▲ 165.80M |
Other Expenses | 1.87M | ▼ 1.06M | ▲ 1.45M | ▲ 4.42M | ▼ 3.54M | ▼ -6.35M | ▲ -610.00K |
Operating Expenses | 202.74M | ▲ 204.59M | ▼ 188.93M | ▲ 191.05M | ▼ 182.25M | ▼ 178.10M | ▲ 202.87M |
Cost And Expenses | 349.21M | ▲ 354.05M | ▼ 336.00M | ▲ 347.30M | ▼ 330.18M | ▲ 341.16M | ▲ 364.91M |
Interest Income | 2.48M | ▲ 2.73M | ▼ 2.17M | ▼ 1.44M | ▲ 5.31M | ▼ 2.68M | ▲ 5.04M |
Interest Expense | 13.93M | ▼ 13.46M | ▲ 17.35M | ▼ 12.13M | ▲ 12.89M | ▲ 18.87M | ▼ 13.62M |
Depreciation And Amortization | 5.22M | ▲ 5.69M | ▼ 4.36M | ▼ 4.08M | ▲ 12.81M | ▲ 30.52M | ▲ 30.57M |
Ebitda | 43.67M | ▲ 50.56M | ▲ 60.63M | ▲ 68.16M | ▲ 80.65M | ▲ 86.40M | ▼ 38.96M |
Ebitda Ratio | 0.11 | ▲ 0.13 | ▲ 0.16 | ▲ 0.17 | ▲ 0.20 | ▲ 0.22 | ▼ 0.11 |
Operating Income | 34.11M | ▲ 36.08M | ▲ 52.65M | ▲ 58.22M | ▲ 67.84M | ▼ 55.88M | ▼ 3.96M |
Operating Income Ratio | 0.09 | ▲ 0.09 | ▲ 0.14 | ▲ 0.14 | ▲ 0.17 | ▼ 0.14 | ▼ 0.01 |
Total Other Income Expenses Net | 1.87M | ▼ -3.94M | ▲ 1.45M | ▲ 4.25M | ▼ -3.63M | ▼ -27.02M | ▲ -610.00K |
Income Before Tax | 24.52M | ▲ 26.41M | ▲ 38.92M | ▲ 51.79M | ▲ 64.21M | ▼ 28.86M | ▼ -5.23M |
Income Before Tax Ratio | 0.06 | ▲ 0.07 | ▲ 0.10 | ▲ 0.13 | ▲ 0.16 | ▼ 0.07 | ▼ -0.01 |
Income Tax Expense | -622.00K | ▲ 11.09M | ▼ -53.83M | ▲ 6.40M | ▲ 11.26M | ▼ 9.02M | ▼ -1.95M |
Net Income | 25.14M | ▼ 15.32M | ▲ 92.74M | ▼ 45.38M | ▲ 52.95M | ▼ 19.83M | ▼ -3.28M |
Net Income Ratio | 0.07 | ▼ 0.04 | ▲ 0.24 | ▼ 0.11 | ▲ 0.13 | ▼ 0.05 | ▼ -0.01 |
Eps | 0.29 | ▼ 0.18 | ▲ 1.10 | ▼ 0.54 | ▲ 0.63 | ▼ 0.25 | ▼ -0.04 |
Eps Diluted | 0.29 | ▼ 0.18 | ▲ 1.09 | ▼ 0.53 | ▲ 0.63 | ▼ 0.25 | ▼ -0.04 |
Weighted Average Shs Out | 86.68M | ▼ 85.87M | ▼ 84.34M | ▲ 84.70M | ▼ 83.65M | ▼ 78.33M | ▼ 77.74M |
Weighted Average Shs Out Dil | 86.68M | ▲ 86.77M | ▼ 84.93M | ▲ 85.78M | ▼ 83.65M | ▼ 78.33M | ▼ 77.74M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 138.84M | ▲ 198.91M | ▲ 470.17M | ▲ 513.45M | ▼ 456.66M | ▼ 276.40M | ▲ 591.91M |
Short Term Investments | 4.65M | ▼ 12.00K | ▼ 0.00 | 0.00 | ▲ 16.68M | ▲ 32.69M | ▲ 71.19M |
Cash And Short Term Investments | 138.84M | ▲ 198.91M | ▲ 470.17M | ▲ 513.45M | ▼ 456.66M | ▼ 309.10M | ▲ 663.10M |
Net Receivables | 265.74M | ▲ 275.30M | ▼ 225.53M | ▲ 231.83M | ▲ 263.47M | ▼ 259.33M | ▼ 241.09M |
Inventory | 280.35M | ▲ 316.05M | ▼ 310.12M | ▲ 317.39M | ▲ 324.58M | ▲ 389.61M | ▲ 403.42M |
Other Current Assets | 90.16M | ▼ 67.91M | ▲ 69.28M | ▲ 91.05M | ▲ 116.79M | ▼ 100.01M | ▲ 1.34B |
Total Current Assets | 775.08M | ▲ 858.17M | ▲ 1.24B | ▼ 1.15B | ▲ 1.16B | ▼ 1.06B | ▲ 1.42B |
Property Plant Equipment Net | 300.11M | ▲ 431.93M | ▼ 371.16M | ▲ 396.25M | ▲ 459.59M | ▲ 496.38M | ▲ 497.19M |
Goodwill | 926.48M | ▲ 954.28M | ▼ 932.37M | ▲ 1.01B | ▲ 1.04B | ▲ 1.06B | ▼ 1.04B |
Intangible Assets | 1.08B | ▼ 1.03B | ▼ 989.44M | ▲ 1.15B | ▼ 1.13B | ▼ 1.07B | ▼ 1.02B |
Goodwill And Intangible Assets | 2.01B | ▼ 1.99B | ▼ 1.92B | ▲ 2.16B | ▲ 2.17B | ▼ 2.12B | ▼ 2.06B |
Long Term Investments | 5.35M | ▼ 0.00 | ▲ 474.83M | ▲ 564.43M | ▲ 567.34M | ▼ 32.18M | ▼ -2.56B |
Tax Assets | 6.81M | ▲ 12.62M | ▲ 73.69M | ▼ 56.95M | ▼ 45.99M | ▲ 46.08M | ▼ 34.18M |
Other Non Current Assets | 14.57M | ▲ 14.64M | ▼ -463.56M | ▼ -547.99M | ▲ -510.15M | ▲ 26.01M | ▲ 2.63B |
Total Non Current Assets | 2.33B | ▲ 2.45B | ▼ 2.38B | ▲ 2.63B | ▲ 2.73B | ▼ 2.72B | ▼ 2.66B |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 3.11B | ▲ 3.30B | ▲ 3.62B | ▲ 3.78B | ▲ 3.89B | ▼ 3.78B | ▲ 4.08B |
Account Payables | 76.05M | ▲ 113.09M | ▼ 54.61M | ▲ 61.84M | ▲ 102.10M | ▼ 92.33M | ▲ 94.40M |
Short Term Debt | 22.50M | ▲ 57.25M | ▲ 159.07M | ▼ 59.78M | ▼ 52.75M | ▼ 29.82M | ▲ 35.68M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 3.76M | ▲ 4.77M | ▲ 5.28M | ▲ 5.30M | ▲ 7.25M | ▲ 8.54M | ▼ 7.84M |
Other Current Liabilities | 160.24M | ▼ 156.19M | ▲ 182.06M | ▲ 213.11M | ▼ 158.80M | ▲ 176.30M | ▼ 164.48M |
Total Current Liabilities | 262.55M | ▲ 331.31M | ▲ 401.01M | ▼ 340.02M | ▼ 320.91M | ▼ 306.98M | ▼ 302.39M |
Long Term Debt | 1.33B | ▲ 1.40B | ▲ 1.50B | ▲ 1.59B | ▼ 1.56B | ▼ 1.49B | ▼ 170.08M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | ▲ 6.70M | ▲ 8.80M | ▼ 7.70M | ▼ -201.51M |
Deferred Tax Liabilities Non Current | 57.78M | ▼ 36.55M | ▼ 16.19M | ▲ 45.79M | ▲ 63.34M | ▼ 35.32M | ▼ 31.43M |
Other Non Current Liabilities | 80.05M | ▲ 118.08M | ▲ 186.73M | ▼ 113.56M | ▲ 129.70M | ▲ 359.09M | ▲ 2.18B |
Total Non Current Liabilities | 1.47B | ▲ 1.56B | ▲ 1.70B | ▲ 1.76B | ▲ 1.76B | ▲ 1.89B | ▲ 2.18B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Capital Lease Obligations | 0.00 | ▲ 109.76M | ▼ 100.94M | ▲ 105.10M | ▲ 172.04M | ▼ 166.85M | ▲ 186.39M |
Total Liabilities | 1.73B | ▲ 1.89B | ▲ 2.10B | ▼ 2.10B | ▼ 2.09B | ▲ 2.19B | ▲ 2.48B |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.30B |
Common Stock | 880.00K | ▲ 887.00K | ▲ 893.00K | ▲ 896.00K | ▲ 905.00K | ▲ 909.00K | ▲ 915.00K |
Retained Earnings | 348.37M | ▲ 398.57M | ▲ 532.27M | ▲ 698.57M | ▲ 879.12M | ▲ 946.86M | ▼ 943.58M |
Accumulated Other Comprehensive Income Loss | -45.44M | ▼ -76.40M | ▲ -74.06M | ▲ -45.16M | ▲ 10.27M | ▼ -15.11M | ▲ -10.65M |
Other Total Stockholders Equity | 1.07B | ▲ 1.09B | ▼ 1.06B | ▼ 1.03B | ▼ 914.12M | ▼ 655.22M | ▲ 664.11M |
Total Stockholders Equity | 1.38B | ▲ 1.42B | ▲ 1.51B | ▲ 1.68B | ▲ 1.80B | ▼ 1.59B | ▲ 2.90B |
Total Equity | 1.38B | ▲ 1.42B | ▲ 1.51B | ▲ 1.68B | ▲ 1.80B | ▼ 1.59B | ▲ 2.90B |
Total Liabilities And Stockholders Equity | 3.11B | ▲ 3.30B | ▲ 3.62B | ▲ 3.78B | ▲ 3.89B | ▼ 3.78B | ▲ 5.38B |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 3.11B | ▲ 3.30B | ▲ 3.62B | ▲ 3.78B | ▲ 3.89B | ▼ 3.78B | ▲ 5.38B |
Total Investments | 10.00M | ▼ 12.00K | ▲ 474.83M | ▲ 564.43M | ▲ 567.34M | ▼ 64.87M | ▲ 71.19M |
Total Debt | 1.35B | ▲ 1.46B | ▲ 1.66B | ▼ 1.65B | ▼ 1.62B | ▲ 1.68B | ▼ 186.39M |
Net Debt | 1.22B | ▲ 1.26B | ▼ 1.19B | ▼ 1.14B | ▲ 1.16B | ▲ 1.41B | ▼ -405.52M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 25.14M | ▼ 15.32M | ▲ 92.74M | ▼ 45.38M | ▲ 52.95M | ▼ 19.83M | ▼ -3.28M |
Depreciation And Amortization | 27.68M | ▲ 27.88M | ▼ 26.18M | ▲ 30.75M | ▼ 29.50M | ▲ 30.52M | ▲ 30.57M |
Deferred Income Tax | -8.97M | ▲ -8.51M | ▼ -68.92M | ▲ 10.74M | ▼ -6.02M | ▼ -14.85M | ▲ -2.86M |
Stock Based Compensation | 4.99M | ▲ 5.51M | ▼ 5.26M | ▲ 6.43M | ▼ 5.73M | ▲ 5.79M | ▼ 5.60M |
Change In Working Capital | -7.88M | ▲ 35.51M | ▼ 9.49M | ▼ -25.25M | ▲ 10.26M | ▼ 10.09M | ▼ -23.35M |
Accounts Receivables | -18.20M | ▲ 8.09M | ▼ -5.76M | ▼ -10.17M | ▲ -10.04M | ▲ -457.00K | ▲ 16.83M |
Inventory | 11.74M | ▼ -12.76M | ▲ -2.82M | ▲ 8.97M | ▼ -4.68M | ▼ -16.42M | ▼ -19.02M |
Accounts Payables | -5.83M | ▲ 14.30M | ▼ 9.67M | ▼ -984.00K | ▲ 18.15M | ▼ 1.91M | ▼ -19.21M |
Other Working Capital | 4.41M | ▲ 25.87M | ▼ 8.40M | ▼ -23.06M | ▲ 6.83M | ▲ 25.06M | ▼ -1.50M |
Other Non Cash Items | 1.73M | ▲ 155.73M | ▼ 69.44M | ▼ -159.15M | ▲ -7.07M | ▲ 7.36M | ▼ 2.00M |
Net Cash Provided By Operating Activities | 42.69M | ▲ 231.43M | ▼ 134.19M | ▼ -91.09M | ▲ 85.33M | ▼ 58.75M | ▼ 15.76M |
Investments In Property Plant And Equipment | -25.69M | ▲ -22.19M | ▼ -28.43M | ▲ -27.49M | ▲ -14.46M | ▼ -24.54M | ▲ -15.47M |
Acquisitions Net | 0.00 | 0.00 | 0.00 | ▼ -190.47M | ▲ -51.51M | ▲ 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -32.69M | ▼ -38.50M |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 355.00K | ▼ -140.47M | ▲ -7.49M | ▲ 315.95M | ▼ 11.15M | ▼ -32.69M | ▼ -38.50M |
Net Cash Used For Investing Activities | -25.33M | ▼ -162.67M | ▲ -35.92M | ▲ 98.00M | ▼ -54.82M | ▼ -57.23M | ▲ -53.97M |
Debt Repayment | -44.96M | ▼ -102.85M | ▲ 20.20M | ▼ -11.25M | ▼ -101.30M | ▲ -6.80M | ▼ -355.40M |
Common Stock Issued | 0.00 | 0.00 | 0.00 | ▲ 236.00K | ▲ 3.87M | ▼ 225.00K | ▲ 6.40M |
Common Stock Repurchased | -406.00K | ▲ -242.00K | ▼ -389.00K | ▼ -515.00K | ▲ -272.00K | ▼ -314.00K | ▼ -3.12M |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -38.69M | ▲ 94.08M | ▼ 1.41M | ▲ 112.26M | ▼ 3.87M | ▼ -314.00K | ▼ -3.12M |
Net Cash Used Provided By Financing Activities | -84.06M | ▲ -8.77M | ▲ 21.22M | ▲ 101.01M | ▼ -97.70M | ▲ -6.89M | ▲ 358.68M |
Effect Of Forex Changes On Cash | -276.00K | ▲ 74.00K | ▲ 8.32M | ▼ 8.05M | ▲ 11.91M | ▼ 8.04M | ▼ -4.96M |
Net Change In Cash | -67.15M | ▲ -9.07M | ▲ 73.89M | ▼ 43.22M | ▼ -55.28M | ▲ 2.67M | ▲ 315.50M |
Cash At End Of Period | 138.84M | ▲ 198.91M | ▲ 470.17M | ▲ 513.45M | ▼ 456.66M | ▼ 276.40M | ▲ 591.91M |
Cash At Beginning Of Period | 205.99M | ▲ 207.98M | ▲ 396.28M | ▲ 470.23M | ▲ 511.94M | ▼ 273.73M | ▲ 276.40M |
Operating Cash Flow | 42.69M | ▲ 231.43M | ▼ 134.19M | ▼ -91.09M | ▲ 85.33M | ▼ 58.75M | ▼ 15.76M |
Capital Expenditure | -25.69M | ▲ -22.19M | ▼ -28.43M | ▲ -27.49M | ▲ -14.46M | ▼ -24.54M | ▲ -15.47M |
Free Cash Flow | 17.00M | ▲ 209.24M | ▼ 105.76M | ▼ -118.58M | ▲ 70.88M | ▼ 34.22M | ▼ 291.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)